IMC Chicago
SLS icon

IMC Chicago’s SELLAS Life Sciences SLS Stock Holding History

IMC Chicago’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.74M Buy
+385,200
New +$4.83M ﹤0.01% 2276

Other funds holding SLS

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
DI
DAGCO Inc Westlake, Ohio $576M AUM 21.79% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Opus Capital Group
Opus Capital Group Cincinnati, Ohio $1.02B AUM 13.75% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $189B AUM 37.1% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

IMC Chicago's SLS Position: Q3 2026 in Review

IMC Chicago opened a new position in SELLAS Life Sciences (SLS) in Q3 2026: 73,637 shares worth $906K. The stake represents ﹤0.01% of the portfolio and ranks #4010 among its holdings.

118 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • IMC Chicago held 73,637 shares of SELLAS Life Sciences worth $906K as of Q3 2026.
  • SELLAS Life Sciences was a new IMC Chicago position in Q3 2026.
  • SELLAS Life Sciences made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #4010 holding.
  • 118 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.